Asset Details
Do you wish to reserve the book?
Mitochondrial Cardiomyopathy and Coenzyme Q^sub 10
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mitochondrial Cardiomyopathy and Coenzyme Q^sub 10
Do you wish to request the book?
Mitochondrial Cardiomyopathy and Coenzyme Q^sub 10
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mitochondrial Cardiomyopathy and Coenzyme Q^sub 10
2014
Overview
Heart mitochondrial oxidative phosphorylation function and coenzyme Q10 (CoQ10) concentration in clinical and experimental cardiomyopathies are presented. In endomyocardial biopsies (EMB) of patients with cardiomyopathy of unknown etiology (CPUE), decreased mitochondrial respiration, ATP production and CoQ10 concentrations have been found. A positive relationship between the degree of rejection, decreased CoQ10 and OXPHOS function in EMB of transplanted hearts has been documented. In experimental medicine circadian and circasemidian rhythms of heart mitochondrial \"CoQ10- CLOCK\" have been found and different parameters of the cascade of oxidative phosphorylation between control and diabetic rats' hearts were estimated. A novel CoQ binding site in Voltage- Dependent Anion Channel (VDAC) of outer mitochondrial membrane is proposed. CoQ10 targeted therapy of damaged mitochondria could be in the site of porin (VDAC) of the outer mitochondrial membrane where exogenous CoQ10 passes through this channel into mitochondria. Based on current knowledge, target of mitochondrial respiratory chain supplementary therapy with CoQ10 in cardiomyopathies is warranted.
